Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

At the June 2024 meeting, the ACIP voted to revise RSV vaccination guidelines. The RSV vaccine was previously recommended for all patients aged 75 and older, with eligibility extended to those ...

Since the ACIP issued the first RSV vaccine recommendation for adults in 2023, the shared decision-making recommendation has proven problematic in clinical practice, Camille Kotton, MD, chair of ...

The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...

Britton A, Roper LE, Kotton CN, et al. Use of respiratory syncytial virus vaccines in adults aged ≥60 years: updated recommendations of the Advisory Committee on Immunization Practices ...

This is a shift from June 21, 2023, when ACIP recommended that adults aged 60 years and older may receive a single dose of the RSV vaccine. 2 These updated recommendations aim to maximize RSV ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu immunizations in 2025. The panel voted to expand RSV protection for infants ...

ACIP's decision was influenced by the outcomes from a Phase III trial that assessed the safety and immune response of the RSV vaccine in the 50 to 59 age group, particularly in those with high ...

All infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, ... “The ACIP’s unanimous recommendations for routine use ...